Maximus, Inc. (NYSE:MMS) Shares Sold by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. lowered its stake in Maximus, Inc. (NYSE:MMS) by 4.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 30,591 shares of the health services provider’s stock after selling 1,560 shares during the period. GHP Investment Advisors Inc. owned 0.05% of Maximus worth $2,284,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Nordea Investment Management AB bought a new stake in Maximus in the fourth quarter valued at about $4,618,000. Fort Washington Investment Advisors Inc. OH grew its position in shares of Maximus by 39.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after acquiring an additional 83,390 shares in the last quarter. Versor Investments LP increased its holdings in shares of Maximus by 213.5% in the 3rd quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after acquiring an additional 5,789 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock valued at $86,552,000 after acquiring an additional 102,350 shares in the last quarter. Finally, Citigroup Inc. lifted its stake in Maximus by 143.3% during the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider’s stock worth $5,538,000 after purchasing an additional 35,012 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on MMS. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research note on Thursday, January 2nd. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday.

Insider Buying and Selling at Maximus

In other Maximus news, CEO Bruce Caswell acquired 3,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average cost of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This represents a 1.28 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by company insiders.

Maximus Trading Down 7.3 %

Shares of NYSE MMS opened at $70.29 on Friday. Maximus, Inc. has a 12-month low of $69.72 and a 12-month high of $93.97. The company has a market cap of $4.01 billion, a price-to-earnings ratio of 14.06 and a beta of 0.72. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock’s 50 day simple moving average is $74.83 and its 200 day simple moving average is $83.53.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 20.95% and a net margin of 5.78%. Equities research analysts expect that Maximus, Inc. will post 5.95 EPS for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.71%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio (DPR) is 24.00%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.